Weiwei Ma

High dose and hepatobiliary dysfunction are associated with hand-foot syndrome in patients with lymphoma using pegylated liposomal doxorubicin: a retrospective study

G. Liang, Qingyuan Zhang, Wen-Wu Zhao, 2021, BMC pharmacology & toxicology.

Adjuvant sorafenib therapy in patients with resected hepatocellular carcinoma: evaluation of predictive factors

Wei Zhang, Ti Zhang, Qiang Li, 2015, Medical Oncology.

High dose and hepatobiliary dysfunction are associated with hand-foot syndrome in patients with lymphoma using pegylated liposomal doxorubicin: a retrospective study

G. Liang, Qingyuan Zhang, Wen-Wu Zhao, 2021, BMC Pharmacology and Toxicology.

A single center experience of sorafenib in advanced hepatocellular carcinoma patients: evaluation of prognostic factors

Wei Zhang, T. Song, D. Kong, 2011, European journal of gastroenterology & hepatology.

Risk factors for pegylated liposomal doxorubicin-induced moderate to severe hand-foot syndrome in breast cancer patients: assessment of baseline clinical parameters

G. Liang, Qingyuan Zhang, Wen-Wu Zhao, 2021, BMC cancer.

Efficacy of intestinal obstruction stent combined with laparoscopic surgery and neoadjuvant chemotherapy in patients with obstructive colorectal cancer

Tie-nan Bi, Weiwei Ma, Leilei Yang, 2019, Oncology letters.

High dose and hepatobiliary dysfunction are associated with hand-foot syndrome in patients with lymphoma using pegylated liposomal doxorubicin: a retrospective study

G. Liang, Qingyuan Zhang, Wen-Wu Zhao, 2021, BMC pharmacology & toxicology.

Adjuvant sorafenib reduced mortality and prolonged overall survival and post-recurrence survival in hepatocellular carcinoma patients after curative resection: a single-center experience.

Wei Zhang, Ti Zhang, Qiang Li, 2014, Bioscience trends.